{
  "ticker": "VCYT",
  "company_name": "Veracyte, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT02609269",
      "title": "Decipher Genomics Resource for Intelligent Discovery",
      "status": "ENROLLING_BY_INVITATION",
      "phase": "",
      "condition": "Prostate Cancer, Bladder Cancer, Renal Cancer",
      "start_date": "2015-10",
      "completion_date": "2040-12",
      "enrollment": 0,
      "sponsor": "GenomeDx Biosciences Corp"
    },
    {
      "nct_id": "NCT07282808",
      "title": "Focal or Radical Therapy: a Lesion-based Molecular Evaluation in Prostate Cancer",
      "status": "RECRUITING",
      "phase": "NA",
      "condition": "Prostate Cancer",
      "start_date": "2026-01",
      "completion_date": "2048-09",
      "enrollment": 0,
      "sponsor": "Singapore General Hospital"
    },
    {
      "nct_id": "NCT06426628",
      "title": "Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Pulmonary Nodule, Solitary, Lung Cancer",
      "start_date": "2022-07-18",
      "completion_date": "2027-03-31",
      "enrollment": 0,
      "sponsor": "Veracyte, Inc."
    },
    {
      "nct_id": "NCT04396808",
      "title": "Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer",
      "status": "RECRUITING",
      "phase": "NA",
      "condition": "Prostate Cancer",
      "start_date": "2020-11-05",
      "completion_date": "2031-04-30",
      "enrollment": 0,
      "sponsor": "University of Michigan Rogel Cancer Center"
    },
    {
      "nct_id": "NCT06282588",
      "title": "Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers",
      "status": "RECRUITING",
      "phase": "PHASE2, PHASE3",
      "condition": "Prostate Cancer",
      "start_date": "2023-12-13",
      "completion_date": "2030-12-31",
      "enrollment": 0,
      "sponsor": "Cancer Research Antwerp"
    },
    {
      "nct_id": "NCT06332274",
      "title": "tislelizUMaB in canceR Patients With molEcuLar residuaL Disease",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Cancer, Lung Cancer, Colo-rectal Cancer, Pancreas Cancer, Soft Tissue Sarcoma",
      "start_date": "2025-04-16",
      "completion_date": "2030-04",
      "enrollment": 0,
      "sponsor": "Gustave Roussy, Cancer Campus, Grand Paris"
    },
    {
      "nct_id": "NCT03769415",
      "title": "Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA",
      "status": "RECRUITING",
      "phase": "NA",
      "condition": "Breast Cancer",
      "start_date": "2018-11-06",
      "completion_date": "2030-12-15",
      "enrollment": 0,
      "sponsor": "UNC Lineberger Comprehensive Cancer Center"
    }
  ],
  "summary": {
    "total_trials": 7,
    "by_phase": {
      "": 2,
      "NA": 3,
      "PHASE2, PHASE3": 1,
      "PHASE3": 1
    },
    "by_status": {
      "ENROLLING_BY_INVITATION": 1,
      "RECRUITING": 6
    },
    "active_trials": 7,
    "completed_trials": 0,
    "conditions": [
      "Breast Cancer",
      "Cancer, Lung Cancer, Colo-rectal Cancer, Pancreas Cancer, Soft Tissue Sarcoma",
      "Prostate Cancer",
      "Prostate Cancer, Bladder Cancer, Renal Cancer",
      "Pulmonary Nodule, Solitary, Lung Cancer"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:43:29.345076",
    "search_query": "Veracyte, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Veracyte,+Inc."
  }
}